Book summary “Essential Oil Safety”: summary

Introduction

You want to use essential oils effectively, but you face conflicting advice regarding their safety and toxicity. Exaggerated claims and incomplete data make it difficult to determine which oils pose real risks and which are safe for daily use.

Robert Tisserand and Rodney Young provide an authoritative guide to essential oil safety based on scientific research and clinical evidence. You will learn how chemical composition, absorption, and metabolism determine the biological action of essential oils on specific organs.

The book explores foundational chemistry, toxicological risk assessment, systemic pharmacokinetics, and detailed profiles of individual oils.

• How do chemical constituents determine toxicity?
• What happens when essential oils enter your bloodstream?
• Which oils present risks to your skin or nervous system?
• How do you calculate safe dilution limits?

1. Essential Oil Composition and Chemistry

Essential oils are complex organic mixtures whose biological and toxicological effects are dictated by their major constituents, chemotypes, and susceptibility to chemical degradation.

Evaluating essential oil safety requires understanding their biological action rather than relying blindly on legal or institutional guidelines. You find that essential oils are complex, volatile organic mixtures obtained from plants primarily through steam distillation or expression, possessing distinct chemical constituents that determine their biological and toxicological effects. There are 350,000 global plant species, of which 5% are aromatic, and 400 commercially processed aromatic plant species exist. A typical fresh plant material yields 1-2% by weight of essential oil on distillation.

Roses are processed via hydrodistillation by boiling rather than steaming, and rose otto is produced this way with a typical yield of 0.015%.

Isolation and Composition

Essential oil composition varies due to environmental and genetic factors, and plants of the same botanical species can produce entirely different major chemical constituents known as chemotypes. Moroccan Eucalyptus globulus oil shows a 1,8-cineole low of 62.4% in May and a high of 82.2% in July. French Mentha x piperita oil exhibits a low of 6.1-8.1% and a high of 48.8-54.5% for menthone across October and June. Italian Salvia officinalis oil ranges from 29.7% to 48.8% for alpha-thujone from April to October.

Essential oils and related aromatic products can contain chemical contaminants such as biocides, residual extraction solvents, and plasticizers like phthalates. Italian citrus oils show a detected range of 0-5.95 ppm for a single pesticide, alongside historical organophosphorus pesticide concentrations from 1.5 ppm to 450 ppm detected since the 1960s. Calabrian bergamot oils from 1999 and 2000 contained phthalates in a concentration range of 1.22-1.65 mg/L per phthalate.

High-value essential oils are frequently subjected to deliberate adulteration using odorous synthetics or non-odorous extenders to increase commercial profit. Synthetic methyl salicylate is sometimes passed off as wintergreen oil, and synthetic benzaldehyde as bitter almond oil.

Degradation and Analysis

Exposure to oxygen, heat, and light causes chemical degradation and oxidation in essential oils, which can reduce their therapeutic efficacy and increase safety hazards like skin sensitization. When lemon oil was stored at 25 degrees Celsius with the cap removed for three minutes daily, its monoterpene content decreased from 97.1% to 30.7% in 12 months.

You can protect your aromatic extracts by following specific storage and handling steps:

• Store essential oils in dark bottles away from direct sunlight and sources of heat.
• Store essential oils in a cool place, such as a refrigerator.
• Refrigerate essential oils that readily degrade and use them within 12 months of end-user purchase or first opening.
• Add an antioxidant such as BHT shortly after extraction to preparations made with oxidation-prone essential oils.

2. Toxicology and Risk Assessment

Toxicology studies harmful events from xenobiotics interacting with living systems. Adverse effects are functional changes causing impairment. Localized acute toxicity affects organs of absorption and elimination like the skin, stomach, liver, intestines, lungs, and kidneys. Individual susceptibility varies based on age, sex, genetics, nutritional status, and health status.

Many toxicological studies create an exaggerated sense of risk by testing unrealistically massive doses on laboratory animals. A National Toxicology Program study on beta-myrcene administered massive daily doses to rats and mice over a two-year period, resulting in animal deaths due to excessive dosing rather than realistic toxicity. Studies often administer extremely high doses that have no relevance to normal therapeutic use, such as a carcinogenesis study of beta-myrcene giving rodents daily oral doses equivalent to 17.5 g, 35 g, or 70 g for a human.

Rigorous toxicological evaluation distinguishes real human risk from exaggerated hazard data, establishing safe exposure thresholds through careful risk assessment.

Measuring Toxicity

Animal toxicity testing uses metrics like the median lethal dose to assess acute and chronic risks, though extrapolating these results to humans presents significant challenges. The conventional measure of acute toxicity is the LD50, representing the dose killing 50% of a test group of animals such as rats or mice. Essential oils generally fall into slightly toxic or non-toxic categories based on rodent LD50 ratings, with lemon oil showing an LD50 of 5 g/kg or more and boldo leaf reaching an acute oral LD50 in rats of 130 mg/kg as the most toxic essential oil. Interspecies differences in toxicokinetics and metabolism mean animals and humans react differently, and wintergreen oil is estimated to be 1.5 to 4.5 times more toxic to humans on a bodyweight basis than it is to rodents.

Essential oils are complex mixtures whose overall toxicity can be influenced by additive, synergistic, or antagonistic interactions between their constituents. When combined oils share toxic constituents, their maximum safe doses must assume additive effects. Interactions between constituents can lead to synergy, where the action is greater than predicted, or antagonism, where it is less. Linalyl acetate, terpineol, and camphor combined showed reduced cell proliferation in human colon cancer cell lines, while carvacrol and thymol exhibited antagonistic effects making thyme oil about half as toxic to predicted levels, yielding a thymol and carvacrol CT thyme oil rat oral LD50 of 4,700 mg/kg and a lemongrass and lemon myrtle skin sensitization limit of 0.7% based on citral. Antioxidants present in essential oils often provide antitoxic or protective effects against harmful compounds.

Serious essential oil poisoning primarily results from accidental oral ingestion of undiluted oil, with young children under six representing the vast majority of cases. Infants and young children are uniquely at risk due to natural inquisitiveness, a tendency to swallow rather than sip liquids, smaller body size, and less effective metabolism. Ingestion of undiluted oils can cause severe symptoms including convulsions, vomiting, and rapid breathing, while 75% of poisoning cases in the USA are in children up to 6 years old. A 10-month-old infant drank approximately 1 oz of camphorated oil after reaching a bottle in her crib, and an Australian report noted 78 out of 109 children aged 5 or less ingested vaporization solutions, contributing to an estimated fatal oral dose of eucalyptus oil in humans ranging from 30 mL to 60 mL alongside several fatal child ingestion cases recorded over a span of 70 years.

Minimizing Risk

Risk assessment frameworks use the no-observed-adverse-effect level derived from animal testing to establish safe limits of exposure for humans. Risk assessment involves hazard identification, dose-response analysis, exposure quantification, and risk characterization. The NOAEL serves as a baseline for calculating acceptable daily intakes and reference doses, traditionally modified by a 100 overall safety factor historically used to account for animal-to-human and human-to-human variations.

Improving packaging with child-resistant closures and flow restrictors significantly reduces the incidence of serious essential oil toxicity cases. While general exposures to essential oils have increased by an 85% growth in essential oil exposures reported in the USA from 1997 to 2006 due to wider usage, serious cases out of total exposures reported to American poison centers dropped from 0.1% in 1997 to 0.05% in 2006 following improvements in packaging. Consumer awareness of the risks essential oils pose to children remains poor, with 81% of surveyed UK parents storing essential oils unsafely among household items, indicating a need for mandatory child-resistant closures and clear hazard labeling.

You must protect vulnerable populations by following specific safety and packaging protocols:

• Identify the hazard by drawing from toxicological and epidemiological data.
• Determine the dose-response relationship or establish an animal NOAEL with uncertainty factors.
• Quantify exposure to determine the amount of a substance individuals and populations will encounter.
• Characterize risk by combining the previous steps and weighting all evidence.
• Review packaging and labeling of potentially toxic essential oils urgently.
• Sell essential oils in bottles equipped with child-resistant tops and restricted flow dispensers.
• Label bottles clearly to indicate that ingestion can be very toxic and requires urgent medical help.
• Ban open-topped bottles of undiluted essential oil lacking drop-dispensers.
• Print appropriate warning labels on essential oil packaging.

3. Absorption, Metabolism, and Pharmacokinetics

Essential oils enter systemic circulation via dermal, pulmonary, or oral routes, undergoing hepatic biotransformation that can either detoxify constituents or generate reactive metabolites.

Bioavailability measures the exact proportion of an administered essential oil dose that reaches the systemic circulation unchanged. Bioavailability depends on the specific substance administered, the mode and route of administration, and the individual recipient. An intravenous injection achieves 100% bioavailability, while all other routes yield lower percentages.

Routes of Administration

Essential oil constituents cross the stratum corneum through passive diffusion via intercellular lipid matrices, transcellular paths, or hair follicles. The stratum corneum acts as a primary protective barrier, but volatile chemicals and lipophilic molecules can penetrate it. Once absorbed, the epidermis can act as a reservoir for up to 72 hours before constituents enter the dermis and blood capillaries.

Jäger et al. (1992a) applied 1.5 g of 2% lavender oil in peanut oil over the abdomen of human subjects for 10 minutes, finding that linalool peaked at 120 ng/mL plasma after 20 minutes.

Certain essential oil constituents and vehicles can disrupt skin lipid integrity, dramatically enhancing their own dermal uptake and that of other topical medications. Terpenes mix with skin lipids, rendering them slightly more hydrophilic to ease passage to the dermis. Pre-treating skin with essential oils can heavily increase the transdermal absorption of prescription pharmaceuticals, creating clinical risks.

Williams and Barry (1989) found that pre-treatment with four essential oils enhanced the dermal absorption of 5-fluorouracil (5-FU) from 2.8-fold for anise oil up to 34-fold for eucalyptus oil.

Age drastically alters skin permeability and metabolic capacity, making premature infants, newborns, and the elderly far more vulnerable to dermal toxicity. Pre-term infant skin before 30 weeks gestation is 100 to 1,000 times more permeable than adult skin due to a poorly formed stratum corneum. Neonatal skin largely matures by 3 months. In elderly individuals, thinning epidermis, increased transepidermal water loss, and slower barrier recovery heighten absorption risks and allergic sensitization.

Inhalation provides highly efficient systemic absorption via the lungs and nasal mucosa, granting direct access to the central nervous system. Alveoli transport small molecules into the blood rapidly, and olfactory membranes absorb volatile components directly into circulation. While general exposure in a room rarely reaches dangerous levels, prolonged sniffing or high vapor concentrations of neurotoxic constituents pose risks.

Falk-Filipsson et al. (1993) exposed eight male volunteers to (+)-limonene at 10, 225, or 450 mg/m3 during light physical exercise, finding up to 70% absorption into the blood at higher doses without adverse symptoms.

Oral administration allows for precise, large-scale dosing and high bioavailability, but magnifies risks of gastrointestinal mucosal irritation, systemic overdose, and first-pass liver metabolism. Typical daily oral doses range from 0.05 to 1.3 mL, which is roughly ten times greater than the amount absorbed from full-body massage. Ingested constituents pass directly to the liver via the portal system, where first-pass metabolism deactivates many compounds or paradoxically converts others into dangerous toxins.

Zimmermann et al. (1995) demonstrated that the bioavailability of 1,8-cineole as the main ingredient in GeloMyrtol forte capsules reached 95.6%.

Metabolism and Drug Interactions

Hepatic biotransformation processes essential oil constituents through Phase I functionalization and Phase II conjugation to make them more hydrophilic for rapid urinary excretion. Phase I reactions include hydrolysis via esterases, oxidation primarily via cytochrome P450 (CYP) enzymes, and reduction. Phase II conjugation reactions attach polar endogenous molecules like glucuronic acid, sulfate, or glutathione to neutralize reactive intermediates, with a 300 Da molecular weight threshold below which glucuronide conjugates are readily excreted in urine.

While metabolism generally detoxifies foreign substances, certain essential oil constituents undergo bioactivation into reactive electrophilic metabolites that cause cellular damage or carcinogenesis. Enzymes in the liver and skin can convert non-toxic or active compounds into harmful epoxides or proximate carcinogens. For example, (+)-pulegone is oxidized by CYP enzymes into menthofuran and reactive intermediates that bind irreversibly to cellular proteins and cause severe hepatotoxicity.

Moorthy et al. (1989b) and Anderson et al. (1996) noted that fatal poisoning with (+)-pulegone can occur alongside very low plasma levels of 18 ng/mL for pulegone and 1 ng/mL for menthofuran.

Essential oil constituents can induce or inhibit cytochrome P450 (CYP) liver enzymes, potentially altering the blood concentrations, therapeutic efficacy, or side effects of co-administered pharmaceutical drugs. Enzyme induction increases medication metabolism and lowers drug blood levels, while enzyme inhibition causes drug levels to rise. Peppermint oil acts as a reversible inhibitor of CYP3A4, significantly increasing the bioavailability of specific medications in clinical tests.

Dresser et al. (2002) showed that oral administration of 600 mg of peppermint oil increased the bioavailability of felodipine in healthy human volunteers by inhibiting intestinal CYP3A4 activity.

Topically applied salicylate derivatives and wintergreen oil can potentiate the action of anticoagulant drugs like warfarin, triggering severe internal hemorrhaging and subcutaneous bruising. High salicylate levels decrease the hepatic synthesis of vitamin K-dependent coagulation factors. Clinical cases reveal that patients liberally applying methyl salicylate balms while taking warfarin suffer catastrophic drops in blood hemoglobin and major bleeding episodes.

Le Bourhis and Soenen (1973) documented an 85-year-old woman taking warfarin who developed gross vaginal bleeding and subcutaneous hemorrhaging after liberally applying a menthol and methyl salicylate preparation to her arthritic joints, dropping her blood hemoglobin from 117 g/L to 80 g/L, noting that wintergreen oil contains 98% methyl salicylate.

4. Organ-Specific Toxicity and Systemic Effects

Essential oil constituents interact directly with the skin, respiratory tract, cardiovascular system, urinary system, digestive organs, nervous system, and reproductive pathways, presenting specific target organ risks.

Dermal and Respiratory Hazards

Inflammation caused by contact with essential oils is broadly categorized into contact dermatitis, which sub-divides into contact dermatitis, irritant contact dermatitis, allergic contact dermatitis, pigmented contact dermatitis, and photosensitization. Irritation can promote sensitization by compromising the skin barrier and granting access to immune cells. Small reactive molecules known as haptens bind with skin proteins to initiate antibody formation and trigger an immune response.

Saint-Mezard et al. (2003a) and Bonneville et al. (2007) investigated how skin concentration and duration of contact with haptens determine whether allergic contact dermatitis develops following initial irritation.

The auto-oxidation of essential oil constituents generates hydroperoxides and oxides that are significantly more sensitizing and reactive than their parent compounds. Karlberg et al. (1994b) demonstrated that adding appropriate antioxidants considerably reduces the rate of oxidation and the formation of allergenic compounds during the auto-oxidation of d-limonene.

When you apply essential oils to the skin, you must manage phototoxic risks. Phototoxicity is a skin reaction occurring when phototoxic chemicals such as furanocoumarins absorb UVA light, forming DNA cross-links that result in severe inflammation, blistering, and hyperpigmentation. A female adult sustained severe full-thickness blistered burns requiring a seven-day hospital stay after applying undiluted bergamot oil to her skin 15 minutes before a 20-minute sunbed session.

Crawford et al. (2004) found in a survey of massage therapists that the use of aromatherapy products increased the risk of hand dermatitis by 3.27 times, while atopic dermatitis yielded an odds ratio of 8.06.

Pungent odorous substances activate trigeminal or vagal afferent C fibers via the common chemical sense, triggering non-allergic irritation distinct from olfaction. Ozone reacts with unsaturated terpenes in indoor air well below their no-observed-effect levels to form irritating compounds and sub-micron particles. When female rats aged 2 months were exposed to a mixture of 6 ppm (+)-limonene and 0.8 ppm ozone for 3 hours, they showed endothelial cell hypertrophy, perivascular and pleural edema, and alveolar septal wall thickening, whereas 18-month-old animals showed only patchy fluid accumulation.

Inhaled pungent substances interact with transient receptor potential ion channels located in the airways, serving as a key mechanism in sensory irritation and hyper-reactivity. Inhaled at 30 mcg/L, (-)-menthol reduced evoked cough in guinea pigs by 56%, and an inhaled mixture of 75% (-)-menthol and 25% 1,8-cineole significantly reduced citric-acid-induced cough in healthy humans.

Introducing essential oil drops directly into the nose of infants can cause severe respiratory distress, acute collapse, and serious central nervous system toxicity. An 18-month-old girl experienced severe respiratory distress after Vicks VapoRub was applied under her nose, prompting label cautions against use on children under 2 years of age.

Internal and Systemic Reactions

Several essential oil constituents act as calcium channel blockers, depressing heart contractility and relaxing vascular smooth muscle. Traditional aromatherapeutic warnings against using hyssop, thyme, rosemary, and sage oils in hypertension lack scientific support. Several essential oils and their constituents possess antiplatelet activity and inhibit blood coagulation, creating risks for individuals on anticoagulant medications.

Severe renal damage and failure from essential oils are rare and exclusively linked to oral overdoses or known toxic substances. A 17-month-old child was given 4 mL of methyl salicylate in error and died; autopsy showed swollen, highly congested kidneys with tubular degeneration. A 31-year-old man suffered acute renal failure after ingesting 10 mL of wormwood oil.

Mucous membranes in the gastrointestinal tract lack a protective keratinized cell layer and are significantly more sensitive and permeable than skin, making oral or rectal administration of undiluted essential oils hazardous. High doses of certain essential oil constituents can deplete hepatic reduced glutathione, leaving liver cells defenseless against reactive free radicals and electrophiles, which can lead to fatal necrosis. An 18-year-old girl ingested 30 mL of pennyroyal oil, resulting in massive hepatic necrosis, coma, and death on the sixth day.

Essential oils containing large amounts of negative-menthol can cause severe adverse reactions, such as neonatal jaundice, in individuals deficient in the enzyme glucose-6-phosphate dehydrogenase. Specific essential oil ketones such as alpha-thujone, beta-thujone, pinocamphone, camphor, and pulegone act as potent CNS stimulants and can trigger seizures at non-lethal doses. A 50-year-old woman suffered a tonic seizure and fractured her skull after ingesting undiluted thuja oil at 20 drops twice a day for 5 days.

Most essential oil constituents possess favorable lipophilicity and low molecular weight, allowing them to cross the placental barrier via passive diffusion and enter the fetal circulation. Following accidental ingestion of camphorated oil by a pregnant woman, camphor was found in the body, liver, brain, and kidney tissue of her stillborn baby. Popular claims that emmenagogic essential oils cause miscarriage are largely unfounded, as oils reputed to be abortifacients generally inhibit uterine contractions and only induce miscarriage through severe maternal toxicity at near-fatal doses.

Essential oils containing high levels of specific toxic constituents such as sabinyl acetate, thujone, or pinocamphone present severe risks of reproductive toxicity and should be avoided throughout pregnancy and lactation. Subcutaneously administered savin oil containing 50% sabinyl acetate prevented implantation in mice when given on gestational days 0 to 4.

• Do not use undiluted essential oils for patch testing.
• Mix the test oil at 5% w/w with petrolatum (petroleum jelly).
• Apply patches to healthy skin on the inside of the forearm or upper back.
• Leave patches in place for 48 hours without washing or exposing the area to sunlight or UV light.
• Make an initial assessment one hour after removal and a second assessment 48 hours later.
• Make a final assessment seven days after application when testing for sensitization.
• Do not expose skin treated with phototoxic oils at levels higher than maximum recommended use levels to UV light for 12 to 18 hours.
• Check with suppliers for phototoxicity risk when using deterpenated citrus oils.
• Use lower concentrations of essential oils for massage.
• Avoid high-risk and moderate-risk essential oils.
• Avoid oxidized essential oils.
• Avoid detergents for hand washing.
• Use hand cream after hand washing.
• Wear thin plastic disposable gloves instead of latex.
• Ensure adequate ventilation in the workspace.
• Minimize indoor concentrations of ozone in aromatherapy treatment rooms by removing sources such as photocopying machines, laser printers, and ozone-generating air cleaners.
• Maintain levels of environmental fragrance at minimal concentrations.
• Apply a maximum of 1% concentration of essential oil for aromatherapy massage in individuals with diagnosed asthma, anyone reporting airway hyper-reactivity to fragrances, paint fumes, or turpentine, and in atopic children.
• Do not apply essential oils with a high content of menthol or 1,8-cineole to the faces of infants or children.
• Avoid oral administration of essential oils that inhibit platelet aggregation if taking anticoagulant drugs such as aspirin, heparin, and warfarin.
• Avoid oral administration of these oils for breastfeeding mothers, individuals with hemophilia, peptic ulcer, internal bleeding, severe hepatic or renal impairment, hypertensive or diabetic retinopathy, thrombocytopenia, or vasculitis.
• Avoid oral administration up to one week before or after major surgery or childbirth.
• Avoid taking undiluted essential oils orally.
• Avoid applying undiluted essential oils to the mouth or rectum.
• Avoid oral administration of essential oils high in pulegone or p-cresol in people with liver disease, alcoholism, or those concurrently taking paracetamol.
• Avoid oral doses of essential oils containing large amounts of negative-menthol for anyone with a G6PD enzyme deficiency.
• Use effective antioxidant systems in preparations containing essential oils prone to oxidation.
• Store products containing essential oils cool, screened from UV rays, and under nitrogen when possible.
• Use oral essential oils listed in Box 7.2 with caution in diabetic subjects whose blood glucose levels are being controlled by orthodox drugs.

5. Cancer, Immunity, and Essential Oil Profiles

Carcinogenesis is classically considered to evolve in three consecutive stages: initiation, promotion, and progression. Compounds like benzyl acetate, dodecyl acetate, alpha-phellandrene, and oxidation products of (+)-limonene act as promoters of skin tumors in mice subsequent to an initiator. Dietary fat can act as an enhancer of cancer induction at 40% of calories.

Evaluating carcinogenic potential and individual essential oil profiles requires balancing genotoxic constituent risks against natural protective mechanisms, antioxidant defenses, and precise usage limits.

Alkenylbenzenes such as alpha-asarone, beta-asarone, estragole, methyleugenol, and safrole are metabolized into proximate carcinogens like 1'-hydroxyestragole, which are further activated into ultimate carcinogens such as 1'-sulfooxyestragole that can bind to DNA. Melatonin inhibited safrole-DNA adducts in rat liver by 98.7%, likely through the activation of protective enzymes like glutathione peroxidase.

Female rats chronically exposed to (E)-anethole exhibited hepatotoxicity and tumors at a dietary intake of 550 mg/kg/day when epoxide production exceeded 120 mg/kg, but no toxicity occurred below 30 mg/kg. The threshold dose for DNA adduct formation for methyleugenol in rats is 34.8 mg/kg/day. Extracts of Piper betle containing safrole are non-carcinogenic due to antagonistic protective constituents until mixed with areca nut in betel quid, where safrole reaches 15 mg/g in betel flowers.

Carcinogenesis and Defense Mechanisms

An adult receiving an aromatherapy massage with 87% methyleugenol tarragon oil absorbs approximately 1.8 mg/kg/day, approaching the rodent threshold, based on a typical amount of 1.5 mL of essential oil and an estimated transdermal absorption rate of 10%. You must observe specific maximum use levels and suspend essential oil use around medical treatments.

• Avoid essential oils from one week before to one month following a course of chemotherapy or radiotherapy.
• Avoid essential oils in patients undergoing organ or tissue transplants who are taking conventional immunomodulatory drugs.

Profiles and Safety Adjustments

Dalmatian sage oil has a maximum dermal use level of 0.4%, but if only 5 g of product is applied, you can increase the concentration to 2.4% using the baseline single application amount of 30 mL. Both lemongrass and lemon myrtle oils share a limit of 0.7% for skin sensitization and teratogenicity, meaning their combined total must not exceed that threshold.

• Adhere to maximum dermal percentages for local skin reactions even if using a smaller total amount of product.
• Increase the maximum concentration proportionally for systemic toxicities when applying a smaller total amount of product topically using the formula: (30 / amount applied in g) multiplied by the standard maximum percentage.
• Calculate combined maximum safe percentages proportionally when mixing oils that share identical toxic constituents or target organ toxicities to ensure the total combined amount does not exceed the individual limit.

10 Key Ideas

1. Essential oil safety relies on understanding complex biological and toxicological properties rather than following blind institutional guidelines.
2. Environmental factors create distinct chemotypes within the same botanical species that produce entirely different major chemical constituents and degradation risks.
3. Rigorous toxicological evaluations distinguish real human risk from exaggerated hazard data by establishing safe exposure thresholds based on reliable data.
4. Essential oils cross the stratum corneum through passive diffusion and can severely alter skin lipid integrity to enhance both their own uptake and that of other topical medications.
5. Hepatic biotransformation processes constituents through Phase I and Phase II pathways, but can paradoxically bioactivate harmless compounds into reactive metabolites like menthofuran.
6. Auto-oxidation generates hydroperoxides and oxides that drastically increase the allergenic potential and skin sensitization risks of parent essential oil constituents.
7. Introducing essential oil drops directly into the noses of infants can cause severe respiratory distress, acute collapse, and serious central nervous system toxicity.
8. Specific essential oil ketones act as potent central nervous system stimulants that trigger seizures in humans at non-lethal doses.
9. Essential oils containing specific toxic constituents like sabinyl acetate or thujone present severe risks of reproductive toxicity and must be avoided throughout pregnancy and lactation.
10. Practitioners must adhere to maximum dermal use levels and calculate combined safety percentages proportionally when mixing oils that share identical toxic constituents.